GrayMatterAI, Inc. Information

GrayMatterAI exists to improve health outcomes and eliminate waste by optimizing each patient’s unique specialty drug prescription decision. We incorporate machine learning and predictive analytics to ensure that patients are getting the most effective treatment for their specific case. This ensures each patient is prescribed a treatment precisely tailored to them, eliminates inappropriate specialty drug use, and lowers the overall cost burden on the healthcare system. Platform: GrayMatterAI Learning Engine (Patent Pending) GrayMatterAI has built a learning engine that can ingest patient data from multiple sources to build a holistic model of a disease state. This model can then be used to answer questions from Payers, Providers and Pharma backed up by Big Data analytics. Products: HEPATITIS C PRODUCT Our HepC Product provides specialty drug prescribing tools for providers. Using real world evidence and individual patient data, our AI driven analytics provide specialty drug prescribing support that optimize clinical and cost outcomes while adhering to clinical best practice. Future Products GrayMatterAI is currently leveraging our Learning Engine to extend decision support and forecasting to Rheumatoid Arthritis, Oncology, and additional auto-immune diseases. For more information please contact us at info@graymatterai.com